Summer Hill

02 9797 3900


02 9550 0288


02 8090 6833


COVID-19 Vaccinations

Update as of May 3 2021:  From Monday, 17th May, the AstraZeneca vaccine will be available from General Practices to all adults 50 years of age or over.  Your Doctors is providing appointments upon request for this vaccine in various blocks of time during the week.  

Please  call one of our sites to book in for your appointment.  Please note that there must be a minimum period of two weeks between having this vaccine and any other vaccine (e.g. flu).  

To prepare yourself, please refer to information provided via the links below:
  • Preparing for COVID-19 Vaccination - you can use this checklist to make sure everything is in order prior to your vaccination.
  • Information on COVID-19 AstraZeneca Vaccine - detailed information about the vaccine which has been provided by the Federal Government.
  • Consent Form for COVID-19 Vaccination - For those patients who are coming to Your Doctors for your AstraZeneca vaccination and this will be your first visit to our practice, please print off this form, complete the questions and sign it.  It should then be sent to the practice along with an up-to-date Health Summary provided by your current doctor.  [If you are one of our current patients, you may wish to read through this prior to your visit.  It can also be printed off, signed and brought with you on the day - but this is not a necessary requirement as the nurse will address all of this with you on the day after your medical record has been reviewed.]
  • After Your COVID-19 Vaccination - you will also be given a printed copy of this document by the nurse after you have had your vaccination.

Do you have flu symptoms?

NSW Health recommends that anyone with symptoms gets tested at a COVID-19 clinic.

Symptoms include fever, cough, sore/scratchy throat, shortness of breath, loss of taste or smell, or unexplained fever. You should self-isolate until you receive your test results.

General COVID-19 Information

With the exception of workers in high-risk clinical settings, there is no requirement for testing asymptomatic people before returning to work.